Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bling Capital is an early-stage venture capital firm founded in 2018 by Ben Ling that invests primarily in seed and pre-seed startups. The firm focuses broadly on software, fintech, marketplaces, consumer, AI, and selected healthcare opportunities, but it is not itself a drug developer, biotech, pharmaceutical, or healthcare operating company. Bling Capital positions itself as helping entrepreneurs find product-market fit and scale, supported by an operator network and product council. The name requested, "Bling Ventures," appears to refer to this investment firm rather than a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bling Ventures.